Frutarom, Switzerland, has penetrated the German vascular health market with its Red Vine Leaf Extract EFLA 945, following the latest European Patent Office (EPO) decision to revoke Böhringer Ingelheim’s patent composition for treatment of chronic venous insufficiencies (CVI) comprising of an extract of red vine leaves.
Raul Cortada, global VP of sales and marketing for Frutarom Health, said: “On September 20, EPO’s final conclusion to revoke this patent opened new horizons for our Vitis vinifera L aqueous extract, Red Vine Leaf EFLA. Our Red Vine Leaf Extract EFLA 945 is scientifically backed by bibliographic studies and its triple-powerful standardisation of three markers: polyphenols, anthocyanins and trans-resveratrol.
“This makes it a cutting-edge natural ingredient in the vascular health market. We have successfully proven to the board of appeal that Böhringer’s patent failed to contain any innovative step. This will help us to open the market to this advanced natural solution, especially in Germany where Böhringer is active.”
EFLA 945 contains high, amounts of polyphenols and anthocyanins (which have a distinctive antioxidant effect) and trans-resveratrol to inhibit the platelet agglutination involved in heavy leg syndrome and varicose veins, the company said. EFLA 945 supports vascular health via three mechanisms countering CVI resulting in vessel protection, promoting lipid metabolism and reducing plaque formation for atherosclerosis.
Cortada added: “One of the most important advantages of EFLA 945 is the synergetic effect of the active ingredients. The result is a powerful nutrient that can target several specific health conditions, including venous insufficiency and even Economy Class Syndrome, medically known as Deep Vein Thrombosis.”
Research with EFLA945 shows it to be extremely potent for LDL-oxidation prevention. It is characterised with a high ORAC value, all together positioning it as an effective ingredient in the vascular health market. Red Vine Leaf Extract EFLA 945 provides excellent solubility for beverage applications due to the water extraction method and is also ideal for use in capsules or tablets forms.
© FoodBev Media Ltd 2022
World Beverage Innovation Awards – NOW OPEN FOR ENTRIES!
The awards celebrate excellence and innovation across the global beverage industry.
Don’t miss out on having your innovations recognised on a global scale.
Deadline for entries 23 July – enter now!
Don’t get left behind
Start your free Foodbev magazine trial today and join thousands of fellow industry professionals in receiving food and drink trends direct to our business.
Click here to start your free trial